bullish

Granules India - Finished Dosages Remain the Key Earnings Driver

172 Views29 Jan 2025 12:45
Broker
Granules India (GRAN) delivered better-than-expected revenue, while EBITDA/PAT stood in line for the quarter. The traction in finished dosage (FDF) remained robust for six quarters now.
What is covered in the Full Insight:
  • Introduction
  • Financial Performance
  • Operational Highlights
  • Management Commentary
  • Conclusion and Outlook
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 23-minute read)
Related Insights
More »
    Loading
Trending Collections
More »
    Loading
Trending Insights
More »
    Loading
Top Unpaywalled Insights
More »
    Loading
Discussions
(Paid Plans Only)
chart-bar
Logo
Motilal Oswal
External broker reports(aggregated public sources)
Motilal Oswal Financial Services Limited
IndiaEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x